Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit (HEPSY)

Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit

Acceptability of Advanced Chronic Liver Disease Screening by Transient Elstography (Fibroscan ®) in Patients Hospitalised in Psychiatric Unit: a Single Center Prospective Study

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders. There are still many barriers to screening and linkage to care for patients having somatic illness. Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs. The aim of this study is to asses acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in a psychiatric unit.

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders. There are still many barriers to screening and linkage to care for patients having somatic illness. Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs. Transient elastography is a useful tool validated for early diagnosis advanced chronic liver disease.It is non-invasive, fast, and gives immediate results. The aim of this study is to assess acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in psychiatric unit. Moreover, we will estimate de prevalence of advanced chronic liver diseases according to specific causes in psychiatry unit We hypothesize that the fact of offering psichiatric patents a non-invasive analysis of hepatic fibrosis will improve the detection of serious liver diseases and linkage to care.

psychiatric disorders, advanced liver disease, alcoholic liver diseases, viral hepatitis, transient elastography (Fibroscan ®)

All patients having psychiatric disorders and hospitalised in a Psychiatry Unit of CHU Montpellier will have an non invasive evaluation of liver fibrosis after giving their consent

A Fibroscan will be performed and the result will be given to the patient. A follow-up will be organized in the event of a diagnosis of severe fibrosis. If the serologies for hepatitis B and C cannont be recovered, patient will be able to benfit from a rapid diagnostic orientation test (TROD) (minimally invasive capillary venous sampling at the fingertip) for these 2 serologies.

Number of patient who are diagnosed with advanced liver disease among patient to whom it was offered.

prevalence of passed or active drug consumption (intraveinous, inhaled or sniffed) in psychiatric patients

correlation between advanced chronic liver diseases and risk factors for liver diseases in psychiatric patients

Number of patients with advanced chronic liver disease among those having risk factors for chronic liver disease

assessment of referral to medical care when advanced fibrosis was diagnosed, regardless of its etiology

Number of patients that have actually came to their medical appoint after advanced fibrosis diagnosis

rate of reasons of refusal according to reason of hospitalization, sector, duration of hospitalization, time spend in study explaination, patient reflection time

Inclusion criteria adults ≥18 years having a psychiatric condition and hospitalized in a psychiatry unit of CHU Montpellier , France patients who lack capacity of consent if legal representative consents involuntary psychiatric hospitalization, if consent is given Exclusion criteria lack of written consent Unable to understand nature and objective of the methodology Pregnant or breast feeding woman Not affiliated with a French social security